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 INTRODUCTION 
 
Acute pancreatitis is an acute inflammation of the pancreas is an increasingly 
common abdominal disorder presenting as major surgical challenge to general 
surgeons worldwide. It is a complex process which varies from mild self 
limiting inflammation to rapidly deteriorating condition which poses a serious 
threat to life. Acute pancreatitis has incidence of around 2.29%. Based on 
severity, acute pancreatitis can be acute edematous; acute persistent; or acute 
hemorrhagic necrotizing. Early identification of patients at risk of developing 
a severe attack has great importance for instituting therapeutic interventions 
and improved outcome. 
 About 10 to 20% of patients experience a severe attack of acute pancreatitis 
(SAP); the rate of mortality in SAP is about 20% of all cases of acute 
pancreatitis. Accurate prediction of severity is important in order to improve 
survival. There are several assessment criteria in order to predict prognosis 
and severity of acute pancreatitis, which help in guiding patient triage and 
management. However, nothing proven to perform significantly better in 
clinical settings than good clinical judgment. Ideal predicting criteria should, 
therefore be simple, non-invasive, accurate and quantitative and assessment 
tests are easily available. 
. 
 
AIMS AND OBJECTIVES OF THE STUDY 
 
1) To assess the accuracy of BISAP scoring system vs RANSON’S scoring 
system in predicting Severity in an attack of acute pancreatitis. 
2) To compare predictability of organ failure, necrosis and mortality between 
BISAP scoring and RANSON’S Scoring system. 
 
 
 
 
 
 
 
 
 
 
  
REVIEW OF LITERATURE 
 
ANATOMY 
The average pancreas weighs between 75 and 125 g and measures 10 to 20 
cm. It lies in the retro-peritoneum just anterior to the first lumbar vertebrae 
and is anatomically divided into four portions, the head, neck, body and tail. 
The head lies to the right of midline within the C loop of the duodenum, 
immediately anterior to the vena cava at the confluence of the renal veins. The 
uncinate process extends from the head of the pancreas behind the superior 
mesenteric vein (SMV) and terminates adjacent to the superior mesenteric 
artery (SMA). The neck is the short segment of pancreas that immediately 
overlies the SMV. The body and tail of the pancreas then extend across the 
midline, anterior to Gerota’s fascia and slightly cephalad, terminating within 
the splenic hilum . 
Arterial Blood Supply 
The pancreas is supplied by a complex arterial network arising from the celiac 
trunk and SMA. The head and uncinate process are supplied by the 
pancreatico-duodenal arteries (anterior and posterior), which arise from the 
hepatic artery via the gastro- duodenal artery (GDA) superiorly and the SMA 
inferiorly. The neck, body, and tail receive arterial supply from the splenic 
arterial system. Several small branches originate from the length of the 
splenic artery, supplying arterial blood flow to the superior portion of the 
organ. The dorsal pancreatic artery arises from the splenic artery and courses 
posterior to the body of the gland to become the inferior pancreatic artery. 
The inferior pancreatic artery then runs along the inferior border of the 
pancreas,  terminating at its tail. 
Venous Drainage 
The venous drainage mimics the arterial supply, with blood  flow from the 
head of the pancreas draining into the anterior and posterior 
pancreaticoduodenal veins. The posterior superior pancreaticoduodenal vein 
enters the SMV laterally at the superior border of the neck of the pancreas. 
The anterosuperiorpancreaticoduodenal vein enters the right gastroepiploic 
vein just prior to its confluence with the SMV at the inferior border of the 
pancreas. The anterior and posteroinferiorpancreatico- duodenal veins enter 
the SMV along the inferior border of the uncinate process. The remaining 
body and tail are drained via the splenic venous system. 
 
 
 
EMBRYOLOGY 
Steps in  development of the pancreas. 
1)      Day 26     -    Dorsal pancreatic duct arises from the dorsal side of the 
duodenum 
2)       Day  32      -     Ventral bud from  hepatic diverticulum 
3)       Day 37         -     Contact occurs between the two buds. Fusion by the  
end of week 6 
4)      Week 6       -      Ventral bud produces the head and uncinate process 
5)      Week 6       -      Ducts fuse 
6)     Week 6      -     Ventral duct and distal portion of  dorsal duct form  duct 
of Wirsung 
7)      Week 6       -     Proximal dorsal duct forms the duct of Santorini 
8)      Month 3    -     Acini appear 
 9)    Months 3–4 -    Islets of Langerhans appear and become biologically 
active. 
 
 
 
ANOMALIES OF THE PANCREAS 
■ Aplasia 
■ Hypoplasia 
■ Hyperplasia 
■ Hypertrophy 
■ Dysplasia 
■ Variations and anomalies of the ducts 
         -  Pancreas divisum 
         -  Rotational anomalies 
■ Annular pancreas 
■ Pancreatic gall bladder 
■ Polycystic disease 
■ Congenital pancreatic cysts 
          -  Cystic fibrosis 
           - vonHippel–Lindau syndrome 
■ Ectopic pancreatic tissue, accessory pancreas 
■ Choledochal cysts 
PHYSIOLOGY 
The human pancreas has both endocrine and exocrine functions. It is mainly 
composed of acinar cells (85% of the gland) and islets cells (2%) embedded 
in a complex extracellular matrix, which comprises 10% of the gland. The 
remaining 3% to 4% of the gland is comprised of the epithelial duct system 
and blood vessels. 
Major Components of Pancreatic Juice 
The main function of the exocrine pancreas is to provide the vast majority of 
the enzymes needed for alimentary digestion. Acinar cells synthesize many 
enzymes (proteases) that digest food proteins such as trypsin, chymotrypsin, 
carboxy-peptidase, and elastase. Under physiologic conditions, acinar cells 
synthesize these proteases as inactive proenzymes that are stored as 
intracellular zymogen granules. With stimulation of the pancreas, these 
proenzymes are secreted into the pancreatic duct and eventually the duodenal 
lumen. The duodenal mucosa synthesizes and secretes enterokinase, which is 
the critical enzyme in the enzymatic activation of trypsin from trypsinogen. 
Trypsin also plays an important role in protein digestion by propagating 
pancreatic enzyme activation through autoactivation of trypsinogen and other 
proenzymes, such as chymotrypsinogen, procarboxypeptidase, and 
proelastase. . In addition to protease production, acinar cells also produce 
pancreatic amylase and lipase, also known as glycerol ester hydrolase, as 
active enzymes. With the exception of cellulose, pancreatic amylase 
hydrolyzes major polysaccharides into small oligosaccharides, which can be 
further digested by the oligosaccharidases present in the duodenal and jejunal 
epithelium. Pancreatic lipase hydrolyzes ingested fats into free fatty acids and 
2-monoglycerides. In addition to pancreatic lipase, acinar cells produce other 
enzymes that digest fat, but they are secreted  asproenzymes, like the 
proteases previously. These include co-lipase, cholesterol ester hydrolase, and 
phospholipase A2. The main function of co-lipase is to increase the activity of 
pancreatic lipase. Cholesterol esters are cleaved by cholesterol ester hydrolase 
into free cholesterol and one fatty acid, phospholipase A2 hydrolyzes 
phospholipids, and pancreatic acinar cells also secrete deoxyribonuclease and 
ribonuclease. These are enzymes required for the hydrolysis of DNA and 
RNA, respectively. Pancreatic enzymes are inactive inside acinar cells 
because they are synthesized and stored as inactive enzymes. In addition to 
this autoprotective mechanism, acinar cells synthesize pancreatic secretory 
trypsin inhibitor, which also protects acinar cells from autodigestion because 
it counteracts premature activation of trypsinogen inside acinar cells.  
Although the concentrations of sodium and potassium are similar to their 
respective concentration in plasma, the concentrations of bicarbonate and 
chloride vary significantly, according to the secretion phase. The mechanism 
responsible of the secretion of bicarbonate was first described in 1988 based 
on in vitro studies. According to this model, extracellular CO2 diffuses across 
the basolateral membrane of ductal cells. Once CO2 is inside pancreatic duct 
cells, it is hydrated by intracellular carbonic anhydrase;  as a result of this 
reaction, HCO3− and H+ are generated. The apical membrane of pancreatic 
duct cells contains an anion exchanger that secretes intracellular HCO3− into 
the lumen of the cell and favors the exchange of luminal Cl−  inside the ductal 
epithelium. Recent studies have shown that this exchanger interacts with the 
cystic fibrosis transmembrane conductance regulator (CFTR). This may 
correlate with the inability of patients with cystic fibrosis to secrete water and 
bicarbonate. Although the nature of this exchanger has not been completely 
elucidated, it is possible that this anion exchanger is an SLC26 family 
member. This family contains different anion exchangers that transport 
monovalent and divalent anions, such as Cl− and HCO3−. Some of these 
exchangers are known to interact with CFTR. In addition to HCO3−, CO2 
hydration also generates H+ ions, which are secreted by Na+ and H+ 
exchangers present in the basolateral membrane of ductal cells. These 
exchangers belong to the SLC9 gene family. The main function of these 
exchangers is to maintain the intracellular pH within a physiologic range. In 
addition, the basolateral membrane of duct cells contains multiple Na+, K+ - 
ATPases that provide the primary force that drives HCO3− secretion; the 
Na+, K+ - ATPase maintains the Na+ gradient used to extrude H+ as well. 
Finally, K+ channels present in the basolateral membrane of acinar cells 
maintain the membrane potential to allow recirculation of K+ ions brought by 
the Na+, K+ pump inside the cell. Once the HCO3− secreted by pancreatic 
duct cells reaches the duodenal lumen, it neutralizes the hydrochloric acid 
secreted by parietal cells. Pancreatic enzymes are inactivated at a low pH; 
therefore, pancreatic bicarbonate provides an optimal pH for acinar cell 
enzyme function. The optimal pH for the function  of chymotrypsin and 
trypsin is from 8.0 to 9.0, for amylase the optimal pH is 7.0, and for lipase it 
is from 7.0 to 9.0. 
Phases and Regulation of Pancreatic Secretion 
Pancreatic exocrine secretion occurs during the interdigestive state and after 
the ingestion of food, which is also known as the digestive state. The same 
phases of secretion that have been identified in the stomach during the 
digestive state have been also described in pancreas. In  first  cephalic phase,  
the pancreas stimulated by  vagus nerve in response to the sight, smell, or 
taste of food. This phase, generally mediated    by  release of   acetylcholine   
at  the terminal endings of postganglionic fibers. The main effect of 
acetylcholine is to induce acinar cell secretion of enzymes. This phase 
accounts for 20% to 25% of the daily secretion of pancreatic juice. The 
second phase of pancreatic secretion is known as the gastric phase. It is 
mediated by vago-vagal reflexes triggered by gastric distention after the 
ingestion of food. These reflexes   induce  acinar cell secretion. It accounts for 
10% of the pancreatic juice produced daily. The most important phase of 
pancreatic secretion is the intestinal phase, which accounts for 65% to 70% of 
the total secretion of pancreatic juice. It is mediated by secretin  and   
cholecystokinin  (CCK). Acidification of the duodenal lumen induces the 
release of secretin by S cells. Secretin was the first polypeptide hormone 
identified more than 100 years ago. It is the most important mediator of the 
secretion of water, bicarbonate, and other electrolytes into the duodenum. 
Secretin receptors are located in the basolateral membrane of all pancreatic 
duct cells but cannot be identified in other pancreatic components, such as 
islet cells, blood vessels, or extracellular matrix. Secretin receptors are 
members of the G protein–coupled receptor super family. The most important 
effect of secretin stimulation is an increase of intracellular cyclic adenosine 
monophosphate (c AMP), which activates the HCO3−-Cl− anion exchanger in 
the apical membrane of pancreatic duct cells. It also increases the activity of 
the enzyme carbonic anhydrase, the excretion of H+ outside the duct cell, and 
the activity of the CFTR. The presence of lipid, protein, and carbohydrates 
inside the duodenum induces the secretion of CCK-releasing factor and 
monitor peptide. Both peptides induce release of CCK by I cells present in the 
duodenal mucosa. Whereas secretin is the main mediator of the secretion of 
water and bicarbonate in the intestinal phase, CCK is the main mediator of the 
secretion of pancreatic enzymes. CCK exerts a number of effects: 1. It travels 
through the bloodstream and induces the release of pancreatic enzymes by 
acinar cells. 2. It induces local duodenal vagovagal reflexes that cause the 
release of acetylcholine, vasoactive intestinal peptide, and gastrin-releasing 
peptide, which promotes the release of pancreatic enzymes. 3. CCK induces 
the relaxation of the sphincter of Oddi.  CCK potentiates the effects of 
secretin, and vice versa. 
 
 
 ACUTE PANCREATITIS 
 
ETIOLOGY 
Approximately 80% of cases are associated with cholelithiasis or sustained 
alcohol abuse; the relative frequency of these two factors depends on the 
prevalence of alcoholism in the population studied. Of the mechanical causes 
of pancreatitis, choledocholithiasis is certainly the most common. The 
majority of nonalcoholic patients with acute pancreatitis will have gallstones 
on examination, and between 36% and 63% will develop recurrent acute 
pancreatitis if stones persist. Approximately 1% of patients undergoing 
endoscopic retrograde cholangiopancreatography (ERCP) develop clinically 
detectable pancreatitis. Several metabolic processes are associated with 
pancreatitis, particularly alcohol abuse. Symptoms and signs of pancreatitis 
are recognized in between 1% and 10% of alcoholic patients, usually after 10 
years or more of heavy ingestion. The precise mechanism of this association 
is not well established but may be related to changes in pancreatic exocrine 
secretion and calculus formation in the pancreatic ducts. Several drugs are 
causally related to pancreatitis, particularly, thiazide diuretics, estrogens, 
azathioprine, and furosemide. Furthermore, in approximately 10% of cases, 
no underlying cause can be identified.  
 Many factors have been causally related to the onset of acute pancreatitis , but 
in many instances the mechanism is poorly understood. The most common 
causes are gallstones and alcohol, accounting for up to 80% of cases, but it is 
not uncommon to diagnose acute pancreatitis in the absence of these 
etiological factors. Therefore it is important that a systematic approach is 
taken to the identification of other, less common, and potentially modifiable, 
factors. The median age of the onset of acute pancreatitis varies with etiology; 
alcohol and drug induced pancreatitis typically present in the third or fourth 
decade compared with gallstone and trauma induced disease in the sixth 
decade. The gender difference is probably more related to etiology: in males 
alcohol is more often the cause while in females it is gallstones. 
Evidence that passage of a gallstone is related to the onset of acute 
pancreatitis comes from the characteristic transient derangement of liver 
function tests and the high retrieval rate of gallstones from feces within 10 
days of an attack of acute pancreatitis compared with those without acute 
pancreatitis (88% vs. 11%). The mechanism by which small gallstones 
migrating down the common bile duct, past the pancreatic duct junction and 
into the duodenum, cause acute pancreatitis is not clear. Opie made the 
seminal observation of a gallstone impacted in the sphincter of Oddi in two 
fatal cases of acute pancreatitis, which lead to the “common channel” 
hypothesis. It was proposed that a gallstone transiently lodged in the distal 
common channel of the ampulla of Vater allowed bile to reflux into the 
pancreatic duct, but this cannot be reliably reproduced in experimental 
models. Another proposal suggested that transient incompetence caused by 
the passage of a stone through the sphincter might allow duodenal fluid and 
bile to reflux into the pancreatic duct, but this is refuted by the usual absence 
of acute pancreatitis after endoscopic sphincterotomy or surgical 
sphinteroplasty. A third possibility is that acute pancreatitis is due to a 
gallstone obstructing the pancreatic duct, leading to ductal hypertension. It 
has been postulated that this backpressure might lead to minor ductal 
disruption, extravasation of pancreatic juice into the less alkaline interstitium 
of the pancreas, and promotion of enzyme activation. When gallstones and 
other etiological factors cannot be identified there is still the possibility of 
finding microlithiasis, seen as birefringent crystals, on bile microscopy. 
Alcohol 
Alcohol ingestion is associated with acute pancreatitis and sustained alcohol 
ingestion is associated with recurrent acute pancreatitis and development of 
chronic pancreatitis in susceptible individuals who have been drinking for 
more than a decade.  The type of alcohol consumed is less important than the 
amount consumed (typically 100 to 150 grams per day) and the pattern of  
drinking. It is common for patients with alcohol associated acute pancreatitis 
to have a history of excess alcohol consumption prior to the first attack. There 
are several mechanisms by which ethanol causes acute pancreatitis. Ethanol is 
a metabolic toxin to pancreatic acinar cells and causes a brief secretory 
increase followed by inhibition. The secretory burst coupled with ethanol 
induced spasm of the sphincter of Oddi is thought to incite acute pancreatitis. 
Ethanol also induces ductal permeability, which would allow prematurely 
activated enzymes to cause damage to the pancreatic parenchyma. The  
protein plugs may also contribute by causing an obstructive element to 
pancreatic outflow. 
Effects of alcohol on pancreas. 
Hypertriglyceridaemia, fatty acids and ethyl ester metabolites → pancreatic 
injury  Formation of pancreatic juice which contains high enzymes but low 
enzyme inhibitors → enzyme activation within pancreas;  precipitation of 
proteins, intraductal plug forma- tion, ductal hypertension and obstruction → 
pancreatic injury. Formation of O2 free radicals inside the pancreas → 
pancreatic injury  Direct pancreatic acinar injury   Sphincter of Oddi spasm by 
alcohol leading into ductal obstruction  Repeated subclinical acute 
pancreatitis causes ﬁbrosis and chronic pancreatitis  
Iatrogenic         
 Acute pancreatitis can result from a number of treatments, including 
pancreatic biopsy, exploration of the extrahepatic biliary tree and ampulla of 
Vater, distal gastrectomy, splenectomy, colectomy, nephrectomy, aortic 
aneurysmorraphy, and retroperitoneal lymphadenectomy. As the pancreas is 
susceptible to ischemia it can also occur secondary to splanchnic 
hypoperfusion with cardio-pulmonary bypass or cardiac transplant. Most 
commonly, acute pancreatitis occurs as a complication of ERCP in 5% to 
10% of procedures, and in many series it is the third most common identified 
etiological factor. The risk of post-ERCP acute pancreatitis is increased if the 
contrast agent is infused repeatedly under high pressure by the endoscopist. 
Recent evidence demonstrates that the risk can be decreased with 
prophylactic, rectally administered, nonsteroidal drugs. 
Hereditary pancreatitis 
Hereditary pancreatitis – an autosomal dominant disorder usually due to 
mutations of the cationic trypsinogen gene (PRSS1).This  cause premature 
activation of trypsinogen to trypsin and cause abnormalities of ductal 
secretion, both of which promote acute pancreatitis. Mutations in  SPINK1 
protein,  blocks  active binding site of trypsin, is also likely to have a role in 
predisposing to acute pancreatitis. Variations in penetration and phenotype are 
common and there are many other mutations that may become implicated. 
Tumors 
A pancreatic or periampullary tumor should be considered in any patient with 
idiopathic acute pancreatitis. If no historical information leads to an etiologic 
diagnosis, cross sectional pancreatic imaging after the resolution of an 
unexplained episode of acute pancreatitis is indicated. 
 
Hyperlipidemia 
Patients with  I and V  type of hyperlipoproteinemia can have episodes of 
abdominal pain, and these often occur in association with marked 
hypertriglyceridaemia. Lipase is thought to liberate toxic fatty acids into the 
pancreatic microcirculation, leading to microcirculatory impairment and 
ischemia. Dietary modifications to restrict triglycerides are usually effective, 
but clofibrate may be prescribed in refractory cases. 
Infection 
Infection is commonly polymicrobial (60%). It may be from gallbladder, 
colon or small bowel via transmural migration or by haematogenous spread. 
Infection rate in one week is 24% and in 3 weeks it is 70%. 
• E. coli (35%). 
• Klebsiella (25%). 
• Enterococcus (25%). 
• Others—staphylococci, Pseudomonas, Proteus, Entero- bacter, 
Anaerobes, Candida (10%). 
Drugs and Miscellaneous Causes 
Many drugs can produce hyperamylasemia and/or abdominal pain, and a drug 
is considered suspect if the pancreatitis-like illness resolves with its 
discontinuation. Ethical considerations generally rule out rechallenge with the 
suspect drug, so the connection  often remains vague. However, despite these 
limitations, certain drugs are known to be capable of causing acute 
pancreatitis. These include the thiazide diuretics, furosemide, estrogens, 
azathioprine, l-asparaginase, 6-mercaptopurine, methyldopa, the 
sulfonamides, tetracycline, pentamidine, pro- cainamide, nitrofurantoin, 
dideoxyinosine, valproic acid, and acetylcholinesterase inhibitors. In addition, 
lipid-based intravenous drugs and solutions, such as propofol, can also cause 
acute pancreatitis. A history of verified or suspected drug-induced pancreatitis 
should serve as a contraindication to prescribing that medication again. 
Hypercalcemic states due to hyperparathyroidism cause hypersecretion and 
formation of calcified stones intraductally resulting in acute pancreatitis. Also 
implicated are infestations by Ascarislumbricoides and the liver fluke 
Clonorchissinensis, which is endemic to China, Japan, and Southeast Asia. 
These cause Oriental cholangitis, which is associated with 
cholangiocarcinoma obstructing the pancreatic duct. Other implicated factors 
include azotemia, vasculitis, and the sting of the Trinidadian scorpion 
Tityustrinitatis. This scorpion’s venom has been shown to cause 
neurotransmitter discharge from cholinergic nerve terminals, leading to 
massive production of pancreatic juice. Poisoning with antiacetylcholine 
esterase insecticides has a similar effect. 
 
 
PATHOPHYSIOLOGY 
Acute pancreatitis occurs in various degrees of severity, the determinants of 
which are multifactorial. 
Precipitating Initial Events 
Acinar Cell Events 
Acute pancreatitis is an inflammatory disorder believed to begin in the 
pancreas and is generally restricted to it; although in some cases its effects 
can be systemic, diverse and result in multiple organ failure. In 1896, Chiari 
advanced the understanding of acute pancreatitis by proposing the concept 
that the pancreatitis is essentially the premature, intrapancreatic activation of 
digestive enzymes, resulting in auto-digestion of the organ. Since then the 
intra-acinar activation of zymogens has been demonstrated consistently in 
multiple animal models of acute pancreatitis and is considered a central piece 
in the puzzle of acute pancreatitis. The key role of trypsin activation in acute 
pancreatitis has gained additional support from recent studies showing that 
mice lacking trypsinogen-7 (the isoform of trypsinogen which is activated 
during acute pancreatitis in mice) have significantly less pancreatic injury 
during acute pancreatitis and that intra-acinar expression of active trypsin 
causes pancreatitis in mice. The role of trypsin activation in the 
pathophysiology of acute pancreatitis has also been suggested by clinical 
studies; e.g., hereditary pancreatitis is associated with mutations that lead to 
elevated intracellular trypsin activation and activation of trypsinogen has been 
demonstrated in clinical pancreatitis as well. The mechanisms by which 
injurious stimuli lead to intra- acinar activation of trypsinogen and 
autodigestion of the gland have been the focus of research in pancreatitis for 
decades. Because the exocrine pancreas produces enzymes that are potentially 
injurious to it, several protective mechanisms have evolved to prevent 
autodigestion under normal conditions. Enzymes formed as inactive 
precursors called proenzymes or zymogens, which are then transported and 
secreted outside the gland. Their activation occurs safely in the duodenum, 
where the  trypsinogen is activated to trypsin by entropeptidase, which then 
activates  other zymogens in a cascade reaction. This separates the site of 
production of these enzymes from the site of activation and thus the pancreas 
is insulated against enzymatic attack. Within the acinar cell itself, the 
potentially harmful digestive enzymes are segregated from the surrounding 
cytoplasm by being enclosed within membrane-bound organelles referred to 
as zymogen granules. Another layer of protection is provided by the synthesis 
of trypsin inhibitors, which are transported and stored along with the digestive 
enzyme zymogens. These are available to inhibit small amounts of 
prematurely activated trypsinogen within the pancreatic acinar cells. It is 
theorized that acute pancreatitis occurs when this process goes away and the 
gland is injured by the erroneously- activated  enzymes that it produces. 
Although the mechanism(s) of erroneous activation are not fully understood, 
it has been shown that intra-acinar activation of trypsinogen goes hand-in-
hand with inhibition of acinar secretion. Furthermore, in the presence of 
injurious stimuli, the zymogens responsible for initiating the disease are not 
secreted outside, but are observed to co-localize with cytoplasmic vacuoles 
that contain lysosomal enzymes such as cathepsin B. Data suggest that 
cathepsin B in these vacuoles activates trypsinogen. Thus, inhibition of 
cathepsin B by pharmacological inhibitors or by genetic deletion of cathepsin 
B eliminates trypsin activation and decreases the severity of pancreatitis in 
animal models. What leads to the coming together of zymogens and 
lysosomal hydrolases is unclear, but injurious stimuli leading to sustained 
cytosolic calcium increase have been indicted.  Blocking this calcium increase 
prevents co- localization and activation of trypsin, and decreases injury due to 
pancreatitis. Based on these data, pre-ERCP supplementation  of magnesium, 
a natural antagonist of calcium, is currently being evaluated as a strategy to 
decrease post-ERCP pancreatitis. How activation of trypsin in the co-
localization vacuoles leads to pancreatic damage is also not clear. Recent 
work has led to the novel hypothesis that the lysosomal hydrolase cathepsin B 
activates trypsinogen to trypsin within the co-localization vacuoles. Trypsin 
then permeabilizes these co-localization vacuoles causing the release of 
cathepsin B into the cytosol. Once in the cytosol, cathepsin B initiates 
apoptotic cell death by permeabilizing mitochondrial membranes, which 
allows cytochrome C to be released into the cytosol. This initiates the 
apoptotic cascade and results in the apoptotic death of the acinar cells. 
Intrapancreatic Events 
Activated neutrophils are attracted to a focus of tissue injury and after 
activation release superoxides (the “respiratory burst”) and proteolytic 
enzymes (cathepsins, elastase and collagenase) which cause further injury. In 
addition macrophages release cytokines (including tumor necrosis factor-
alpha (TNF-α), interleukin (IL)-6, and IL-8) which mediate the local and the 
systemic inflammatory responses. These inflammatory mediators cause an 
increased pancreatic vascular permeability, leading to edema, hemorrhage, 
and microthrombi. Fluid may collect in and around the pancreas. The failure 
of the pancreatic micro-circulation, a feature of more severe acute 
pancreatitis, results in pancreatic hypoperfusion and necrosis. Acute 
inflammation of the pancreatic parenchyma and peripancreatic tissues, but 
without recognizable necrosis is termed interstitital edematous 
pancreatitis.When necrosis is present, and evidenced by pancreatic 
hypoperfusion with constrast CT, it is termed necrotizing pancreatitis. 
Systemic Events 
An important aspect of the pathophysiology of acute pancreatitis is the 
mechanism by which events occurring in the pancreas induce systemic 
inflammation and multiorgan failure. The NFκB- dependent inflammatory 
pathway is one such key pathway. NFκB activation parallels trypsin 
activation in acute pancreatitis but appears to be independent of it. The role of 
trypsin in NFκB activation was debated for a long time, but this issue seems 
to be largely settled following the observation that NFκB activation still 
occurs in acini from trypsin knockout mice, which obviously do not have 
pathologic trypsin activation. However, sustained calcium increase, which 
leads to trypsinogen activation, is critical for NFκB activation as well, since 
attenuation of cytosolic calcium also abrogates NFκB activation. Once 
activated, NFκB regulates synthesis of multiple cytokines and chemokines,  
then magnify and propagate systemic inflammation. Once recruited to the 
pancreas, various inflammatory cells lead to  acinar cell injury and cause  an 
elevation of  pro-inflammatory mediators  as TNF-α;  IL-2, IL-2, IL-6, and 
other chemokines and anti-inflammatory factors. Elucidation of these 
mediators has encouraged efforts to target their production or activity with an 
aim to modulate the course of severe acute pancreatitis. Organ failure can 
develop at any stage of acute pancreatitis, associated with an overwhelming 
proinflammatory response early, or later secondary to the development of 
infected local complications. The drivers of the systemic response are poorly 
understood, although factors include the elaboration of proinflammatory 
cytokines, and it appears that mesenteric lymph, bypassing the liver and 
containing these constituents, may contribute to the development of organ 
failure. The development of pancreatic necrosis, the breakdown of the 
intestinal barrier and the suppression of the immune response through the 
compensatory inflammatory response contribute to  development of infection 
in the pancreatic necrosis,  incidence of which peaks in the third to fourth 
week. This is usually associated with deterioration in the patient and may be 
associated with the late development of multi-organ dysfunction 
syndrome/failure (MODS/F) and systemic inflammatory response syndrome 
(SIRS)  Organ failure is scored using the Marshall or Sequential Organ 
Failure Assessment (SOFA) systems . The three organ systems most 
frequently involved are cardiovascular, respiratory, and renal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CLINICAL MANIFESTATIONS 
The cardinal symptom of AP is epigastric and/or periumbilical pain that 
radiates to the back. Up to 90% of patients have nausea and/or vomiting that 
typically does not relieve the pain. The nature of the pain is constant; 
therefore, if the pain disappears or decreases, another diagnosis should be 
considered. Dehydration, poor skin turgor, tachycardia, hypotension, and dry 
mucous membranes are commonly seen in patients with AP. Severely 
dehydrated and older patients may also develop mental status changes. The 
physical examination of the abdomen varies according to the severity of the 
disease. With mild pancreatitis, the physical examination of the abdomen may 
be normal or reveal only mild epigastric tenderness. Significant abdominal 
distention, associated with generalized rebound and abdominal rigidity, is 
present in severe pancreatitis. Note the nature of the pain described by the 
patient may not correlate with the physical examination or the degree of 
pancreatic inflammation. Rare findings include flank and periumbilical 
ecchymosis (Grey Turner and Cullen’s signs, respectively). Both are 
indicative of retroperitoneal bleeding associated with severe pancreatitis. 
Patients with concomitant choledocholithiasis or significant edema in the 
head of the pancreas that compresses the intra- pancreatic portion of the 
common bile duct can present with jaundice. Dullness to percussion and 
decreased breathing sounds in the left or, less commonly, in the right 
hemithorax suggest pleural effusion secondary to AP. 
DIAGNOSIS 
The cornerstone of the diagnosis of AP are the clinical findings plus an 
elevation of pancreatic enzyme levels in the plasma. A threefold or higher 
elevation of amylase and lipase levels confirms the diagnosis. Amylase’s 
serum half-life is shorter as compared with lipase. In patients who do not 
present to the emergency department within the first 24 or 48 hours after the 
onset of symptoms, determination of lipase levels is a more sensitive indicator 
to establish the diagnosis. Lipase is also a more specific marker of AP 
because serum amylase levels  can be elevated in a number of conditions, 
such as such as  peptic ulcer disease, mesenteric ischemia, salpingitis, and 
macroamylasemia. Patients with AP are typically hyperglycemic; they can 
also have leukocytosis and abnormal elevation of liver enzyme levels. The 
elevation of alanine aminotransferase levels in the serum in the context of AP 
confirmed by high pancreatic enzyme levels has a positive predictive value of 
95% in the diagnosis of acute biliary pancreatitis. 
Imaging Studies 
Although simple abdominal radiographs are not useful to diagnose 
pancreatitis, they can help rule out other conditions, such as perforated ulcer 
disease. Nonspecific findings in patients with AP include air-fluid levels 
suggestive of ileus, cutoff colon sign as a result of colonic spasm at the 
splenic flexure, and widening of the duodenal C loop caused by severe 
pancreatic head edema. The usefulness of ultrasound to diagnose pancreatitis 
is limited by intra-abdominal fat and increased intestinal gas as a result of the 
ileus. Nevertheless, this test should always be ordered in patients with AP 
because of its high sensitivity (95%) in diagnosing gallstones. Combined 
elevation of liver transaminase and pancreatic enzyme levels, and the 
presence of gallstones on ultrasound have an even higher sensitivity (97%) 
and specificity (100%) for diagnosing acute biliary pancreatitis. Contrast-
enhanced computed tomography (CT) is currently the best modality to 
evaluate the pancreas, especially if the study is performed using a multi-
detector CT scanner. The most valuable contrast phase to evaluate the 
pancreatic parenchyma is the portal venous phase (65 to 70 seconds after 
contrast injection), which allows evaluation of the viability of the pancreatic 
parenchyma amount of peripancreatic inflammation and presence of intra-
abdominal free air or fluid collections. Non- contrast CT scanning may also 
be of value in the setting of renal failure by identifying fluid collections 
and/or extraluminal air. Abdominal magnetic resonance imaging (MRI) is 
also useful to evaluate the extent of necrosis, inflammation, and presence of 
free fluid. However, its cost and availability, and the fact that patients 
requiring imaging are critically ill and need to be in intensive care units, limit 
its applicability in the acute phase. Although magnetic resonance 
cholangiopancreatography (MRCP) is not indicated in the acute setting of AP, 
it has an important role in the evaluation of patients with unexplained or 
recurrent pancreatitis because it allows complete visualization of the biliary 
and pancreatic duct anatomy. In addition, IV administration of secretin 
increases pancreatic duct secretion, which causes a transient distention of the 
pancreatic duct. For example, secretin MRCP is useful in patients with AP 
and no evidence of a predisposing condition to rule out pancreas divisum, 
intra- ductal papillary mucinous neoplasm (IPMN), or the presence of a small 
tumor in the pancreatic duct. In the setting of gallstone pancreatitis, 
endoscopic ultra- sound (EUS) may play an important role in the evaluation 
of persistent choledocholithiasis. Several studies have shown that routine 
ERCP for suspected gallstone pancreatitis reveals no evidence of persistent 
obstruction in most cases and may actually worsen symptoms because of 
manipulation of the gland. EUS has been proven to be sensitive for 
identifying choledocholithiasis; it allows for examination of the biliary tree 
and pancreas with no risk of worsening the pancreatitis. In patients in whom 
persistent choledocholithiasis is confirmed by EUS, ERCP can be used 
selectively as a therapeutic measure. 
 
 
 
 
 
 
ASSESSMENT OF SEVERITY OF DISEASE 
The earliest scoring system designed to evaluate the severity of AP was 
introduced by Ranson and colleagues in 1974. It predicts the severity of the 
disease based on 11 parameters obtained at the time of admission and/or 48 
hours later. The mortality rate of AP directly correlates with the number of 
parameters that are positive. Severe pancreatitis is diagnosed if three or more 
of the Ranson criteria are fulfilled. The main disadvantage is that it does not 
predict the severity of disease at the time of the admission because six 
parameters are only assessed after 48 hours of admission. Ranson’s score is 
mainly used to rule out severe pancreatitis or predict the risk of mortality. AP 
severity can also be addressed using the Acute Physiology and Chronic 
Health Evaluation (APACHE II) score. Based on the patient’s age, previous 
health status, and 12 routine physiologic measurements, APACHE II provides 
a general measure of the severity of disease. An APACHE II score of 8 or 
higher defines severe pancreatitis. The main advantage is that it can be used 
on admission and repeated at any time. However, it is complex, not specific 
for AP, and based on the patient’s age, which easily upgrades the AP severity 
score. APACHE II has a positive predictive value of 43% and a negative 
predictive value of 89%. Using imaging characteristics, Balthazar and 
associates have established the CT severity index. This index correlates CT 
findings with the patient’s outcome. In 1992, the International Symposium on 
Acute Pancreatitis defined severe pancreatitis as the presence of local 
pancreatic complications (necrosis, abscess, or pseudocyst) or any evidence of 
organ failure. Severe pancreatitis is diagnosed if there is any evidence of 
organ failure or a local pancreatic complication C-reactive protein (CRP) is an 
inflammatory marker that peaks 48 to 72 hours after the onset of pancreatitis 
and correlates with the severity of the disease. A CRP level 150 mg/mL or 
higher defines severe pancreatitis. The major limitation is that it cannot be 
used on admission; the sensitivity of the assay decreases if CRP levels are 
measured within 48 hours after the onset of symptoms. In addition to CRP, a 
number of studies have shown other biochemical markers (e.g., serum levels 
of procalcitonin, IL-6, IL-1, elastase) that correlate with the severity of the 
disease. However, their main limitation is their cost and that they are not 
widely available. 
 
 
 
 
 
 
 
 
 
 
Definitions Proposed by the International Symposium on Acute Pancreatitis  
Acute 
pancreatitis 
Acute inflammatory process of the pancreas with variable 
involvement of other regional tissues or remote organ 
systems. 
Severe AP Association with organ failure and/or local complications, 
such as necrosis, abscess, or pseudocyst. 
Acute          
fluid    
collection 
Occurs early in the course of AP, located in or near the 
pancreas, always lacking a wall of granulation or fibrous 
tissue; bacteria variably present; occurs in 30–50% of severe 
AP;  
Pancreatic 
necrosis 
Diffuse or focal area(s) of nonviable pancreatic parenchyma, 
typically associated with peripancreatic fat necrosis, 
diagnosed by CT scan with intravenous contrast 
enhancement. 
Acute 
pseudocyst 
Collection of pancreatic juice enclosed by a wall of fibrous 
or granulation tissue, which arises as a consequence of AP, 
pancreatic trauma, or chronic pancreatitis; formation requires 
4 or more weeks  
Pancreatic 
abscess 
Circumscribed intra-abdominal collection of pus usually in 
or near the pancreas, containing little or no pancreatic 
necrosis, arises as a consequence of AP or pancreatic trauma. 
 
 
 
SCORING IN ACUTE PANCREATITIS 
CTSI 
Balthazar score is used in CT severity index (CTSI) for grading of acute 
pancreatitis. CTSI includes grading of pancreatitis (A-E) and the extent of 
pancreatic necrosis. 
Grading of pancreatitis 
•A: normal pancreas: 0 
•B: enlargement of pancreas: 1 
•C: inflammatory changes in pancreas and peripancreatic fat: 2 
•D: ill defined single fluid collection: 3 
•E: two or more poorly defined fluid collections: 4 
Pancreatic necrosis  
•none: 0 
•less than/equal to 30%: 2 
•>30-50%: 4 
•>50%: 6 
The maximum score that can be obtained is 10. 
 
Stratification of pancreatitis severity 
•mild pancreatitis (interstitial pancreatitis): Balthazar B or C, without 
pancreatic or extrapancreatic necrosis 
•intermediate (exudative pancreatitis): Balthazar D or E, without pancreatic 
necrosis; peripancreatic collections are due to extrapancreatic necrosis 
•severe pancreatitis (necrotising): with pancreatic necrosis 
Necrosis of the pancreas, visualised best on contrast enhanced CT as non-
enhancing areas, is considered to represent severe pancreatitis. 
BISAP SCORE 
Bedside index of severity in acute pancreatitis (BISAP) score   
• BUN >25 mg/dl (8.9 mmol/L) 
• Abnormal mental status with a Glasgow coma score <15 
• Evidence of SIRS (systemic inflammatory response syndrome) 
• Patient age >60 years old 
• Imaging study reveals pleural effusion 
Systemic inflammatory response syndrome was defined as two or more of the 
following: temperature of <36°C or >38°C, PaCO2 <32 mmHg or respiratory 
rate >20 breaths/min, pulse >90 beats/min, and white blood cell count <4000 
or >12 000 cells/mm3 or >10% immature bands. 
RANSON’S CRITERIA 
For non-gallstonepancreatitis, the parameters are: 
At admission: 
1. Age in years > 55 years 
2. White blood cell count > 16000 cells/mm3 
3. Blood glucose > 11 mmol/L (> 200 mg/dL) 
4. Serum AST > 250 IU/L 
5. Serum LDH > 350 IU/L 
Within 48 hours: 
1. Serum calcium < 2.0 mmol/L (< 8.0 mg/dL) 
2. Hematocrit fall > 10% 
3. Oxygen (hypoxemia PaO2 < 60 mmHg) 
4. BUN increased by 1.8 or more mmol/L (5 or more mg/dL) after IV 
fluid hydration 
5. Base deficit (negative base excess) > 4 mEq/L 
6. Sequestration of fluids > 6 L 
 
 
For gallstone pancreatitis, the parameters are: 
At admission: 
1. Age in years > 70 years 
2. White blood cell count > 18000 cells/mm3 
3. Blood glucose > 12.2 mmol/L (> 220 mg/dL) 
4. Serum AST > 250 IU/L 
5. Serum LDH > 400 IU/L 
Within 48 hours: 
1. Serum calcium < 2.0 mmol/L (< 8.0 mg/dL) 
2. Hematocrit fall > 10% 
3. Oxygen (hypoxemia PaO2 < 60 mmHg) 
4. BUN increased by 0.7 or more mmol/L (2 or more mg/dL) after IV 
fluid hydration 
5. Base deficit (negative base excess) > 5 mEq/L 
6. Sequestration of fluids > 4 L  
 
Interpretation of scores: 
• If the score ≥ 3, severe pancreatitis likely. 
• If the score < 3, severe pancreatitis is unlikely 
• Score 0 to 2 : 2% mortality 
• Score 3 to 4 : 15% mortality 
• Score 5 to 6 : 40% mortality 
• Score 7 to 8 : 100% mortality 
Criteria for organ failure based on Marshall scoring system 
ORGAN SYSTEM   SCORE   
 0 1 2 3 4 
Respiratory (PaO2 / 
FiO2) 
>400 301-400 201-300 101-200 <101 
Renal(serum 
creatinine,mg/dl) 
<1.5 >1.5to<1.9 >1.9to<3.5 >3.5to<5 >5 
Cardiovascular(SBP 
in mm Hg) 
>90 <90,fluid 
responsive 
<90, fluid 
unresponsive 
<90, 
ph<7.3 
<90, 
ph<7.2 
 
 
 Organ failure is defined as a score of ≥ 2 in one or more of the three 
(respiratory, renal, and cardiovascular) out of the five organ systems . 
 
 
 
TREATMENT 
Regardless of the cause or the severity of the disease, the cornerstone of the 
treatment of chronic pancreatitis is aggressive fluid resuscitation using 
isotonic crystalloid solution. The rate of administration should be 
individualized and adjusted based on age, comorbidities, vital signs, mental 
status, skin turgor, and urine output. Patients who do not respond to initial 
fluid resuscitation or have significant renal, cardiac or respiratory 
comorbidities often require invasive monitoring with central venous access 
and a Foley catheter. In addition to fluid resuscitation, patients with AP 
require continuous pulse oximetry because one of the most common systemic 
complications of AP is hypoxemia caused by the  acute lung injury associated 
with this disease. Patients should receive supplementary oxygen to maintain 
arterial saturation above 95%. It is also essential to provide effective 
analgesia. Narcotics are usually preferred, especially morphine. One of the 
physiologic effects described after systemic administration of morphine is an 
increase in tone in the sphincter of Oddi; however, there is no evidence that 
narcotics exert a negative impact in the outcome of patients with AP. There is 
no proven benefit in treating AP with antiproteases (e.g., gabexatemesilate, 
aprotinin), platelet-activating factor inhibitors (e.g., lexipafant), or pancreatic 
secretion inhibitors. Nutritional support is vital in the treatment of AP. Oral 
feeding may be impossible because of persistent ileus, pain, or intubation. In 
addition, 20% of patients with severe AP develop recurrent pain shortly after 
the oral route has been restarted. The main options to provide this nutritional 
support are enteral feeding and total parenteral nutrition (TPN). Although 
there is no difference in the mortality rate between both types of nutrition, 
enteral nutrition is associated with less infectious complications and reduces 
the need for pancreatic surgery. Although TPN provides most nutritional 
requirements, it is associated with mucosal atrophy, decreased intestinal blood 
flow, increased risk of bacterial overgrowth in the small bowel, antegrade 
colonization with colonic bacteria, and increased bacterial translocation. In 
addition, patients with TPN have more central  line infections and metabolic 
complications (e.g., hyperglycemia, electrolyte imbalance). Whenever 
possible, enteral nutrition should be used, rather than TPN. Given the 
significant increase in mortality associated with septic complications in severe 
pancreatitis, a number of physicians advocated the use of prophylactic 
antibiotics in the 1970s. Recent meta-analyses and systematic reviews that 
have evaluated multiple randomized control trials have proven that 
prophylactic antibiotics do not decrease the frequency of surgical 
intervention, infected necrosis, or mortality in patients with severe 
pancreatitis. In addition, they are associated with gram-positive cocci 
infection such as by Staphylococcus aureus, and Candida infection, which is 
seen in 5% to 15% of patients. 
 
 
 
Surgical Management: 
Surgical therapy for acute pancreatitis may address either the etiology of 
pancreatitis or its complications. Operations addressing etiology generally are 
limited to interventions to eliminate cholelithiasis and thus eliminate gallstone 
pancreatitis. For patients with known gallstone pancreatitis, cholecystectomy 
is recommended after resolution of the pancreatic inflammation. Preoperative 
endoscopic examination of the common bile duct is common in some 
institutions; if choledocholithiasis is detected on ERCP, endoscopic duct 
clearance often is attempted, with or without endoscopic papillotomy. In the 
absence of endoscopic interrogation and clearance of the biliary system, 
cholecystectomy should be combined with intraoperative cholangiogram, with 
or without common bile duct exploration. 
The surgical management of the long-term complications of pancreatitis, such 
as pseudocysts and strictures, is addressed elsewhere. The primary surgical 
dilemma presenting in an acute or subacute fashion is surgical management of 
necrotizing pancreatitis. 
 
Resection 
Pancreatic resection for acute pancreatitis is primarily of historical interest 
only and is not recommended currently. Several authors in the 1960s and 
1970s recommended partial or total pancreatectomy for pancreatitis based on 
the possibility that the remaining pancreas could be a source of persistent 
inflammation. Operative mortality was as high as 60% in one series. Although 
others have reported more acceptable mortality, conventional imaging and 
staging systems were not applied universally. In addition to the hazards posed 
by the dissection of a highly vascularized organ amid an acute inflammatory 
process, resection risks overtreatment of many patients if performed for 
necrotizing pancreatitis. Viable tissue typically exists adjacent to necrotic 
tissue, and intraoperative differentiation between healthy pancreatic 
parenchyma and necrotic tissue can prove difficult. For instance, even with 
apparent total necrosis, the central pancreas surrounding the main pancreatic 
duct often is viable and is important for endocrine and exocrine function after 
resolution of the acute disease. Resection therefore inevitably would risk the 
loss of viable, functioning parenchyma. Anatomic resection for pancreatitis, 
with or without associated pancreatic necrosis, therefore is thought to serve 
little utility and potentially may confer significant risk. 
 
Pancreatic Debridement 
All techniques of pancreatic debridement and post debridement care are based 
on two principles: (1) wide removal of devitalized and necrotic tissue with 
thorough exploration and unroofing of all collections of solid and liquid 
debris and (2) the assurance of postoperative removal of the products of 
ongoing local inflammation and infection that persist after debridement. 
Various techniques of open pancreatic debridement for necrotizing 
pancreatitis have been advocated in the literature. While different approaches 
are fundamentally equal in terms of the method of debridement, post 
debridement strategies differ considerably. 
Techniques of Debridement 
Prior to surgical debridement, accurate preoperative imaging is essential. It is 
of paramount importance to identify all areas of necrosis or fluid collections 
to guide surgical exploration properly. To achieve this, a high-quality CT scan 
with intravenous contrast enhancement is essential to identify areas of 
pancreatic or peripancreatic tissue requiring drainage. Exploration of the 
pancreatic bed may be initiated via either a bilateral subcostal or midline 
incision . The pancreatic bed and lesser sac may be approached either through 
the gastrocolic ligament or through the transverse mesocolon. Some authors 
have strongly advocated an approach to the lesser sac via the left side of the 
transverse mesocolon to avoid the dense inflammatory process that can 
obscure tissue planes between the stomach and transverse colon . If the 
anatomic plane between the stomach and colon is obliterated by 
inflammation, the transmesocolic approach avoids inadvertent injury to these 
structures. The middle colic vessels present a potential anatomic barrier to the 
transmesocolic approach, although these vessels often are thrombosed in the 
setting of necrotizing pancreatitis. If patent, these vessels often may be 
interrupted without consequence because the colon is supplied with collateral 
vasculature. An additional advantage of the transmesocolic approach is that 
drains may be placed in a dependent position after debridement. Other 
investigators have advocated an approach to the lesser sac via the 
gastrocolicligament  for the primary reason that the inframesocolic space 
typically is uninvolved with peripancreatic inflammation and infection. 
Moreover, transmesocolic exposure opens the remainder of the abdomen to 
this inflammatory process. 
Pancreatic debridement is accomplished bluntly, primarily using finger 
dissection. The differentiation between necrotic tissue, which has a looser 
consistency, and viable tissue, which is firm, often is best made by palpation. 
Necrotic tissue should separate easily from the surrounding tissue without 
extensive dissection. While complete debridement is essential, efforts should 
be made to avoid overzealous handling of inflamed tissue, which encourages 
bleeding. Debridement therefore should be limited to all clearly necrotic 
tissue that is easily separable from surrounding structures. All fluid as well as 
necrotic tissue is sent for aerobic and anaerobic culture. Hemorrhage from 
diffuse oozing from inflamed retroperitoneal tissues is not uncommon; 
hemostasis may require packing of the cavity. Rapid hemorrhage from the 
intraoperative rupture of a major blood vessel, such as the splenic artery or 
vein, may require suture ligature. Precise vascular control in an inflamed 
tissue field can prove difficult if not impossible. If such is the case, 
hemostasis may require prolonged manual compression and possibly multiple 
sutures. 
As the inflammatory mass is exposed during the course of the debridement, it 
may become necessary to extend the intra-abdominal dissection to fully 
expose all necrotic tissue. A complete search for and identification of all 
necrotic foci must take place. For necrosis of the head, improved exposure 
may be achieved either through the right side of the mesocolon or via an 
approach posterior to the second and third portions of the duodenum. 
Additional exposure also may entail a release of the hepatic and splenic 
flexures of the colon. Thorough exposure of all necrotic tissue may involve 
opening both paracolic gutters, the pararenal spaces, the retroperitoneum into 
the pelvis, and the gastrohepaticomentum. 
 
Debridement and Closed Drainage 
Several authors have demonstrated very favorable results with debridement 
and closed drainage. Proponents of this technique stress that the presence of 
residual necrotic pancreatic tissue is the most important factor dictating the 
need for subsequent reexplorations, each of which is associated with some 
morbidity and mortality. For this reason, the completeness of the initial 
debridement is the most crucial factor in avoiding subsequent re-explorations. 
In contrast to the open packing technique, a concerted effort is made to 
perform a complete debridement and drainage of fluid collections at the first 
surgical procedure. All necrotic tissue is debrided unless it is densely adherent 
to vital structures, and all spaces involved on preoperative imaging are opened 
and debridement done. Debridement is followed with gentle irrigation . The 
cavities left after debridement are drained with either closed-suction drains or 
Penrose drains stuffed with gauze. All drains are brought out through separate 
stab wounds in the abdomen. The placement of enteral feeding or drainage 
tubes (i.e., gastrostomy or jejunostomy) is optional. Drains are removed one 
at a time beginning 6 to 10 days after surgery in an effort to allow the cavity 
to collapse. If Penrose and closed-suction drains are used together, closed-
suction drains are removed last and only when their output is minimal. 
In some cases, complete debridement is not possible during the first 
exploration. If hemodynamic instability or coagulopathy prohibit further 
debridement, temporary closure is achieved after packing the necrotic cavity 
with Mikulicz pads and placing drains; repeat procedures may occur in 24 to 
48 hours, along with additional procedures such as gastrostomy or 
jejunostomy. 
Reported mortality for debridement and closure over drains has been as high 
as 40%. Recurrent pancreatic infection is an acknowledged complication of 
this technique, with early series reporting a recurrence rate of 30–40%. 
However, a more recent series has reported significantly better results, with 
mortality of 6.2%. In this series, an additional operation was required in 17% 
of patients, most of whom had persistent infected pancreatic necrosis. In 
addition, 20% required postoperative image-guided drainage of residual or 
recurrent fluid collections. Overall, 69% required only one operation without 
further procedures. The reported success of this procedure and rate of 
recurrence are attributed to thorough surgical debridement with maximal 
removal of necrotic tissue at the first operation. 
Open Packing for Pancreatic Necrosis 
 A recognized complication after an apparently adequate pancreatic 
debridement is recurrent pancreatic sepsis. While most necrotic debris is 
separated easily from surrounding structures, some borderline tissue may not 
be debrided so easily. Presumably, pancreatic necrosis is an ongoing process, 
and further demarcation of necrotic tissue after an initial debridement can 
result in a mass of particulate matter that is inadequately removed by sump 
drainage. Furthermore, the persistence of necrotic tissue is combined with the 
persistent postoperative leakage of activated pancreatic enzymes from the 
necrotic and inflamed tissue into the retroperitoneum. This combination of 
necrotic material and chemical inflammation may be responsible for the 
occasional failure of simple debridement and drainage. For this reason, some 
authors have advocated a process of open packing, or marsupialization, by 
which recurrent pancreatic debridement is facilitated. 
The surgical approach typically is a left subcostal incision, which is extended 
easily to a bilateral subcostal incision should additional exposure be 
necessary. This transverse incision optimally is situated above a transverse 
opening in the gastrocolicomentum to facilitate open packing. Advocates of 
open packing have preferred to access the lesser sac via the gastrocolic 
ligament, which may provide a more direct access to the entire pancreatic bed 
for future packing. Pancreatic debridement using blunt finger dissection is 
employed, with wide exposure of all areas of retroperitoneal necrosis. 
However, unlike procedures with planned closed packing, no effort should be 
made to remove every identifiable piece of necrotic tissue at the first 
procedure; rather, only tissues that are separated easily by blunt dissection 
should be dissected. Complete removal of all necrotic tissue is accomplished 
by multiple re-explorations and blunt debridements, limiting blood loss. 
After debridement, the stomach and colon may be covered with a non-
adherent gauze to prevent debridement of healthy tissue during dressing 
changes. This constructs a cone or cylinder with the pancreas at the base. 
Laparotomy pads or other gauze may be placed directly within this area, and 
some authors have recommended presoaking these packs in iodinated 
solutions. Some surgeons will suture the gastrocolic ligament to the skin, 
creating an inverted cone with the base consisting of the divided gastrocolic 
ligament at the skin level and the point at the pancreatic bed. However, in the 
setting of acute inflammation, this cavity may be ill defined, and suturing to 
the skin generally is not necessary. No attempts usually are made to close the 
fascia or skin, although occasionally a small number of extraperitoneal stay 
sutures of nylon may be tied loosely to discourage evisceration. This results in 
an open communicating defect for packing. Alternatively, some have used a 
separate retroperitoneal incision through which to bring packs, closing the 
abdominal incision. This method likely provides inferior access for future 
debridement. 
Planned re-explorations are performed in the operating room at 2- to 3-day 
intervals for additional debridement. When retroperitoneal granulation tissue 
begins to form, daily dressing changes may be performed in the ICU using 
mild sedation and/or pain control. Although the majority of necrotic tissue is 
debrided with the first effort, significant amounts of tissue may be removed at 
the fourth or even fifth debridement procedure. 
After debridement has been achieved by open packing, the abdominal wound 
either may be left to heal entirely by secondary intention or may undergo 
delayed primary closure. In some cases, the open packing procedure may be 
combined with delayed closure over lavage catheters and continuous closed 
lavage of the lesser sac and abscess cavity. Catheters are withdrawn gradually 
over weeks after it is demonstrated that there is no pancreatic fistula. 
 
Debridement and Continuous Closed Postoperative Lavage of the Lesser Sac 
After an initial pancreatic debridement, small amounts of residual necrotic 
tissue inevitably are present. Furthermore, the persistent soilage of the 
retroperitoneum with pancreatic enzymes and inflammatory mediators also 
may contribute to persistent systemic inflammation and sepsis. Removal of 
residual necrotic tissue, bacteria, and biologically active substances therefore 
is proposed to decrease persistent inflammation. 
While some have advocated open packing and planned repeated operations to 
accomplish this goal, others report success with continuous postoperative 
high-volume lavage of the lesser sac. Even an aggressive initial debridement 
therefore is not considered an end in itself but rather the first step of a 
thorough washout of the pancreatic bed. 
Beger and colleagues have been written extensively on the procedure of 
debridement and continuous closed postoperative lavage. With this technique, 
pancreatic debridement is performed in the standard fashion. Postoperative 
lavage is facilitated by the insertion of two to five large double-lumen tubes. 
After drain placement, the gastrocolic ligament may be sutured to form a 
closed compartment in the lesser sac. Continuous lavage is undertaken with 
hyperosmolar, potassium-free dialysate at approximately 2 L/h, although 
irrigation with normal saline is also employed. Branum and colleagues 
describe the completion of one or more debridement, followed by the 
placement of multi-lumen sump drains for postoperative irrigation. Irrigation 
continues until the effluent is free of particulate matter. These drains are 
downsized gradually and eventually withdrawn. 
Beger and colleagues have published an overall operative mortality of 10.6% 
with this procedure and a mortality of 15% when the procedure is performed 
for infected pancreatic necrosis. These authors and others have argued that 
using postoperative continuous lavage results in decreased rates of 
postoperative pancreatic sepsis compared with closed drainage techniques, 
and the incidence of postoperative complications such as incisional hernia and 
gastrointestinal fistulas is said to be less than that with open packing and 
repeated debridements. 
Comparison of Techniques Used in Pancreatic Debridement 
As noted earlier, the benefits of various techniques of pancreatic debridement 
and post debridement care have been debated in the literature. No strict 
criteria have been proposed to select patients adequately for different 
procedures, and the optimal method of debridement has not been examined in 
a prospective fashion. A number of case series have been reported in which 
patients with either pancreatic necrosis or severe acute pancreatitis have 
undergone pancreatic debridement followed by either closure over drains, 
open packing and redebridement, or closure over lavage catheters with 
postoperative continuous lavage.  Preoperative disease severity is difficult to 
standardize across different reports, as are the criteria for operative 
management employed. Earlier studies did not employ currently accepted 
criteria of disease severity, and the presence of pancreatic infection is not 
universally documented via preoperative studies. The various methods of 
pancreatic debridement have not been compared in a prospective, randomized 
fashion. 
One small single-institution retrospective study compared surgical outcomes 
in 86 patients with acute pancreatitis after debridement and closed drainage, 
debridement with open packing, or debridement with continuous closed 
postoperative lavage. Patients were noted to have similar preoperative 
Ranson’s scores. Mortality was significantly higher after closed drainage 
(48.4%) compared with 15% following open packing, and complications were 
not significantly different between the groups. However, pancreatic necrosis 
and the time to operation are not documented, so it is not clear that these 
results are applicable to current practice. 
Several series in the literature have quoted a high rate of recurrent pancreatic 
sepsis and high rate of reoperation when the technique of debridement and 
closure over drains is used. Bradley has quoted a rate of re-exploration for 
recurrent sepsis of 30–40%, and a review of large series suggests that the 
majority of postoperative deaths after closed drainage are due to persistent or 
recurrent infection. These figures have been used to argue for either repeated 
pancreatic debridement via open packing or continuous postoperative 
pancreatic lavage. However, the Massachusetts General Hospital experience 
with the closed drainage technique reports a mortality of 6.2%, the lowest 
reported mortality rate in any series of pancreatic debridement for pancreatic 
necrosis. 
Bradley reported a favorable mortality rate of 14% mortality rate for the 
technique of open packing. Given a need for reoperation in up to 30–40% of 
patients after closed drainage or high-volume lavage, an argument then is 
made for controlled, planned re-exploration to achieve thorough debridement. 
Others have suggested that the open packing technique might be particularly 
useful in patients with a larger mass of necrotic tissue. However, 
postoperative morbidity can be considerable with the open packing technique. 
Bradley reported a rate of incisional hernia of 23% after open packing. 
Although this complication is not reported widely in other series, one other 
series has reported a hernia rate of 80%. An increased rate of gastrointestinal 
fistulas has been reported in some series of open packing, although a brief 
review of published series shows that this complication is not universal. As 
with other complications, however, the precise definition of gastrointestinal 
fistula is not clarified in different series. Length of hospital stay, which is not 
reported commonly in different series, has been suggested to be prolonged 
after open packing. 
The recent trend toward delayed surgical therapy for pancreatic necrosis may 
facilitate atraumatic debridement because necrosis becomes increasingly 
organized and demarcated from viable tissue over time. Some investigators 
have suggested that a policy of delayed exploration and debridement therefore 
may facilitate closed drainage without packing or postoperative lavage. In the 
previously mentioned 2001 series of 99 patients with pancreatic necrosis 
managed conservatively at the Brigham and Women’s Hospital, operation 
was offered only for documented infection or for sterile pancreatic necrosis 
with persistent systemic illness. In this series, Ashley and colleagues 
demonstrated that most patients were managed with closed drainage. The 
mean interval from presentation to surgery was 27 days. Of these patients, 31 
(86%) were managed with debridement and closure over drains, 1 received 
postoperative irrigation, and 4 required open packing and planned re-
exploration. Nineteen patients (34%) developed complications, including 9% 
each with pancreatic or enteric fistulas and 15% with endocrine or exocrine 
insufficiency. Of patients managed with closure over drains, only 4 (13%) 
needed re-exploration owing to inadequate persistent illness and presumed 
inadequate debridement. We continue to believe that each technique has its 
place. When early operation is mandated, open packing or lavage may be 
necessary to deal with the consequences of ongoing necrosis. If operation can 
be delayed, debridement with closed drainage and sometimes even internal 
drainage may be adequate. 
Minimally Invasive Approaches 
Although mortality after open pancreatic debridement has decreased in recent 
years, many series still demonstrate a mortality rate of approximately 15%; in 
addition, the mortality in patients with established organ failure may exceed 
75%. Open approaches often are associated with initial postoperative 
deterioration requiring intensive physiologic support. Given the considerable 
morbidity, organ failure, and mortality associated with traditional open 
pancreatic debridement, some investigators have suggested that minimally 
invasive surgical procedures may be used successfully with pancreatic 
necrosis. Avoiding open debridement has the theoretical advantage of 
minimizing activation of systemic inflammatory processes and reducing 
respiratory and wound complications. 
The use of minimally invasive techniques undoubtedly can reduce the severity 
of systemic sepsis and organ dysfunction associated with open pancreatic 
debridement. The primary risk of these procedures is an inadequate 
debridement of solid necrosum and inadequate drainage of the pancreatic bed. 
No randomized studies exist to compare these techniques with traditional 
open debridement. Furthermore, studies are difficult to compare given small 
sample sizes, the retrospective nature of reports, and varying comorbidities 
and selection criteria. For the current time, open surgical debridement 
continues to be the “gold standard” treatment for surgical management of 
pancreatic necrosis. However, as management strategies become more 
nonoperative, it is likely that minimally invasive and percutaneous techniques 
will play an increasing role in the treatment of pancreatic necrosis in the 
future. 
 
 
 
 
 
COMPLICATIONS OF ACUTE PANCREATITIS 
I. Local 
A. Pancreatic phlegmon 
B. Pancreatic abscess 
C. Pancreatic pseudocyst 
D. Pancreatic ascites 
E.  Involvement of adjacent organs, with hemorrhage, thrombosis, bowel 
infarction, obstructive jaundice, fistula formation, or mechanical obstruction 
II. Systemic 
A. Pulmonary 
1. Pneumonia, atelectasis 
2. Acute respiratory distress syndrome 
3. Pleural effusion 
B. Cardiovascular 
1. Hypotension 
2. Hypovolemia 
3. Sudden death 
C. Hematologic 
1. Hemoconcentration 
2. Disseminated intravascular coagulopathy 
D. GI hemorrhage 
1. Peptic ulcer 
2. Erosive gastritis 
3. Portal vein or splenic vein thrombosis with varices 
E. Renal 
1. Oliguria 
2. Azotemia 
3. Renal artery/vein thrombosis 
F. Metabolic 
1. Hyperglycemia 
2. Hypocalcemia 
3. Hypertriglyceridemia 
4. Encephalopathy 
5. Sudden blindness (Purtscher’s retinopathy) 
G. Central nervous system 
1. Psychosis 
2. Fat emboli 
3. Alcohol withdrawal syndrome 
H. Fat necrosis 
1. Intra-abdominal saponification 
2. Subcutaneous tissue necrosis 
 
Sterile and Infected Peripancreatic Fluid Collections 
 The presence of acute abdominal fluid during an episode of AP has been 
described in 30% to 57% of patients. In contrast to pseudocysts and cystic 
neoplasias of the pancreas, fluid collections are not surrounded or encased by 
epithelium or fibrotic capsule. Treatment is supportive because most fluid 
collections will be spontaneously reabsorbed by the peritoneum. The presence 
of fever, elevated white blood cell (WBC) count, and abdominal pain suggest 
infection of this fluid and percutaneous aspiration is confirmatory. 
Percutaneous drainage and IV administration of antibiotics should be 
instituted if infection is present. 
 
Pancreatic Necrosis and Infected Necrosis 
 Pancreatic necrosis is the presence of nonviable pancreatic parenchyma or 
peripancreatic fat; it can present as a focal area or diffuse involvement of the 
gland. Contrast-enhanced CT is the most reliable technique to diagnose 
pancreatic necrosis. It is typically seen as areas of low attenuation (<40 to 50 
HU) after the injection of IV contrast. Normal parenchyma usually has a 
density of 100 to 150 HU. Up to 20% of patients with AP develop pancreatic 
necrosis. It is important to identify and provide proper treatment of this 
complication because most patients who develop multiorgan failure have 
necrotizing pancreatitis; pancreatic necrosis has been documented in up to 
80% of the autopsies of patients who died after an episode of AP. The main 
complication of pancreatic necrosis is infection. The risk is directly related to 
the amount of necrosis; in patients with pancreatic necrosis involving less 
than 30% of the gland, the risk of infection is 22%. The risk is 37% for 
patients with pancreatic necrosis that involves 30% to 50% of the gland and 
up to 46% if more than 70% of the gland is affected. This complication is 
associated with bacterial translocation usually involving enteric flora, such as 
gram-negative rods (e.g., Escherichia coli, Klebsiella and Pseudomonas spp.) 
and Enterococcus spp. Infected pancreatic necrosis should be suspected in 
patients with prolonged fever, elevated WBC count, or progressive clinical 
deterioration. Evidence of air within the pancreatic necrosis seen on a CT 
scan confirms the diagnosis but is a rare finding. If infected necrosis is 
suspected, fine-needle aspiration (FNA) should be performed. A positive 
Gram stain and/or culture establish the diagnosis. Although positive cultures 
are confirmatory, a recent review has demonstrated that despite negative 
preoperative cultures, 42% of patients with so-called persistent unwellness 
will have infected necrosis. Once infection has been demonstrated, IV 
antibiotics should be given. Because of their penetration into the pancreas and 
spectrum coverage, carbapenems are the first option of treatment. Alternative 
therapy includes quinolones, metronidazole, third-generation cephalosporins, 
and piperacillin. Definitive treatment for infected pancreatic necrosis is 
surgical debridement with necrosectomy, closed continuous irrigation, and 
open packaging . The overall mortality rate after open necrosectomy is 25% 
to 30%.15 Outcomes are time- dependent, with patients who undergo surgery 
in the first 14 days having a mortality rate of 75%; those who undergo surgery 
between 15 and 29 days and after 30 days have mortality rates of 45% and 
8%, respectively. As a result of the elevated morbidity and mortality rates 
with open debridement, endoscopic and laparoscopic techniques are being 
used more often.  
Pathophysiology of pancreatic necrosis infection 
The acute inflammatory injury that occurs during the first 48 to 72 
hours causes mucosal ischemia and reperfusion injury. Both effects 
favor bacterial overgrowth because they alter local immunity. Mucosal 
ischemia also produces an increase in the permeability of intestinal 
cells, which is initiated 72 hours after the acute episode but typically 
peak 1 week later. These transient episodes of bacteremia are associated  
with pancreatic necrosis infection. Less frequently, distant sources of  
infection such as pneumonia, vascular, or urinary tract infection asso- 
ciated with central lines and catheters are associated with bacteremia  
and pancreatic necrosis. Finally, local contamination after surgery or  
interventionalprocedures such  as ERCP is responsible for necrosis  
infection.  
Mucosal ischemia/ reperfusion injury 
Blood borne dissemination (distant infection) 
Direct contamination (interventional procedure/ surgery) 
Impaired local immunity/ bacterial overgrowth 
↑ Intestinal permeability 
Bacterial translocation 
                                      For patients with severe pancreatitis, early surgery 
may increase the morbidity and length of stay. Current recommendations 
suggest conservative treatment for at least 6 weeks before laparoscopic 
cholecystectomy is attempted in this setting. This approach has significantly 
decreased morbidity. 
 
 
 
Pancreatic Pseudocysts 
Pancreatic pseudocysts occur in 5% to 15% of patients who have 
peripancreatic fluid collections after AP. By definition, the capsule of a 
pseudocyst is composed of collagen and granulation tissue and it is not lined 
by epithelium. The fibrotic reaction typically requires at least 4 to 8 weeks to 
develop. Up to 50% of patients with pancreatic pseudocysts will develop 
symptoms. The presence of persistent pain, early satiety, nausea, weight loss, 
and elevated pancreatic enzyme levels in plasma suggest this diagnosis. The 
diagnosis is corroborated with by CT or MRI. EUS with FNA is indicated for 
patients in whom the diagnosis of pancreatic pseudocyst is not clear. 
Transduodenal endoscopic drainage are safe and effective approaches for 
patients with pancreatic pseudocysts in close contact (defined as <1 cm) with 
the stomach and duodenum. In addition, transpapillary drainage can be 
attempted in pancreatic pseudocysts communicating with the main pancreatic 
duct. For patients in whom a pancreatic duct stricture is associated with a 
pancreatic pseudocyst, endoscopic dilation and stent placement are indicated. 
Surgical drainage is indicated for patients with pancreatic pseudocysts that 
cannot be treated with endoscopic techniques and patients who fail 
endoscopic treatment. Definitive treatment depends on the location of the 
cyst. Pancreatic pseudocysts closely attached to the stomach should be treated 
with a cyst-gastrostomy. In this procedure, an anterior gastrostomy is 
performed. Once the pseudocyst is located, it is drained through the posterior 
wall of the stomach using a linear stapler. The defect in the anterior wall of 
the stomach is closed in two layers. Pancreatic pseudocysts located in the 
head of the pancreas that are in close contact with the duodenum are treated 
with a cystoduodenostomy. Finally, some pseudocysts are not in contact with 
the stomach or duodenum. The surgical treatment for these patients is a Roux-
en-Y cystojejunostomy. Surgical cystoenterostomy is successful in achieving 
immediate cyst drainage in over 90% of cases. Following initial resolution, 
recurrent pseudocyst formation may occur in up to 12% of cases during long-
term follow-up, depending on the location of the cyst and underlying cause of 
the disease. Complications of pancreatic pseudocysts include bleeding and 
pancreaticopleural fistula secondary to vascular and pleural erosion, 
respectively, bile duct and duodenal obstruction, rupture into the abdominal 
cavity, and infection. Percutaneous drainage is only indicated for septic 
patients secondary to pseudocyst infection because it has high incidence  of 
external fistula. 
 
Pancreatic Ascites and Pancreaticopleural Fistulas 
Although very rare, complete disruption of the pancreatic duct can lead to 
significant accumulation of, fluid. This condition should be suspected in 
patients who have an episode of AP, develop significant abdominal distention, 
and have free intra- abdominal fluid. Diagnostic paracentesis typically 
demonstrates elevated amylase and lipase levels. Treatment consists of  
abdominal drainage combined with endoscopic placement of a pancreatic 
stent across the disruption. Failure of this therapy requires surgical treatment; 
it consists of distal resection and closure of the proximal stump. Posterior 
pancreatic duct disruption into the pleural space has been described rarely. 
Symptoms that suggest this condition include dyspnea, abdominal pain, 
cough, and chest pain. The diagnosis is confirmed with chest x-ray, 
thoracocentesis, and CT scan. Amylase levels above 50,000 IU in the pleural 
fluid confirm the diagnosis. It is more common after alcoholic pancreatitis 
and, in 70% of patients, is associated with pancreatic pseudocysts. Initial 
treatment requires chest drainage, parenteral nutritional support, and 
administration of octreotide. Up to 60% of patients respond to this therapy. 
Persistent drainage should also be treated with endoscopic sphincterotomy 
and stent placement. Patients who do not respond to these measures require 
surgical treatment, similar to that described for pancreatic ascites. 
 
Vascular Complications 
Acute pancreatitis is rarely associated with arterial vascular complications. 
The most common vessel affected is the splenic artery, but the superior 
mesenteric, cystic, and gastroduodenal arteries have also been found to be 
affected. It has been proposed that pancreatic elastase damages the vessels, 
leading to pseudoaneurysm formation. Spontaneous rupture results in massive 
bleeding. Clinical manifestations include sudden onset of abdominal pain, 
tachycardia, and hypotension. If possible, arterial embolization should be 
attempted to control the bleeding. Refractory cases require ligation of the 
vessel affected. The mortality ranges from 28% to 56%. Pancreatic 
inflammation can also produce vascular thrombosis; the vessel usually 
affected is the splenic vein but, in severe cases, it can extend into the portal 
venous system. Imaging demonstrates splenomegaly, gastric varices, and 
splenic vein occlusion. Thrombolytics have been described in the acute early 
phase; however, most patients can be managed with conservative treatment. 
Recurrent episodes of upper gastrointestinal bleeding caused by venous 
hypertension should be treated with splenectomy. 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHOD 
 
 SOURCES OF DATA 
All patients admitted to Govt. Stanley hospital with complaints of pain 
abdomen diagnosed to have Acute Pancreatitis on clinical examination and 
further investigations. 
 
RESEARCH DESIGN 
Prospective Study 
 
RESEARCH SETTINGS 
The study will be conducted for Acute pancreatitis patients admitted to Govt. 
Stanley  Hospital, Chennai. 
 
SAMPLE SIZE 
 Sample size consists of 100 patients of acute pancreatitis. 
 
 
CRITERIA FOR SAMPLE COLLECTION 
INCLUSION CRITERIA 
 Patients with history and clinical findings suggestive of acute 
pancreatitis with evidence of bulky edematous pancreas on USG\ CT 
abdomen. 
EXCLUSION CRITERIA 
 Chronic pancreatitis 
PATIENT DATA COLLECTION AND EVALUATION 
All patients who present at Govt. Stanley  Hospital diagnosed as acute 
pancreatitis from February 2015 to September 2015. 
Acute pancreatitis is defined as 2 or more of thefollowing 
- Characteristic abdominal pain. 
- Increased levels of Serum amylase and/or lipase 3 times the normal 
value. 
- Ultrasonography of the abdomen within first 7days of hospitalization 
demonstrating changes consistent with acute pancreatitis. 
BISAP score and RANSONS score is calculated in all such patients based on 
data obtained within 24hrs of hospitalization and at 48 hrs. 
 
OBSERVATION AND RESULTS 
 
This study was conducted in the department of general surgery, Govt. Stanley 
medical college & Hospital, Chennai from feb 2015 to sep 2015. The 100 
persons with features of acute pancreatitis who fulfilled the inclusion criteria 
were enrolled in this study after obtaining an informed consent. 
 
The age group of patients enrolled in the study ranges from 20 to 80 years. 
The peak incidence of the disease was noted in the 4th decade of life. 
 
The length of the hospital stay ranges from 1 day to 32 days. 
The mean length of hospital stay was 12.03 ± 6.8 days. 
 
On clinical presentation, 95 % of patients were presented with abdominal pain 
as chief complaint. Rest of 5 % who didn’t have abdominal pain had vomiting 
and fever as presenting symptoms. 
 
History of consumption of alcohol and the possibility of it being the 
etiological factor were found on 59 patients, gall stone disease was attributed 
in 23 patients. Hyperlipidemia and drugs as causative factor presented in 3& 2 
patients, respectively. There was clear cut history of blunt trauma with CT 
scan showing isolated pancreatic injury presented in two cases. No cause 
could be attributed in the rest of 11 patients. 
 
Out of 100 patients, 86 patients presented with mild and moderately severe 
acute pancreatitis. Out f 14 with severe attack, 4 were expired. 
 
In mild group the BISAP   score ranges from 0 to 2 and in severe group, it 
ranges from 3 to 5. 
 
In mild group the RANSON’S score ranges from 0 to 3 and in severe group it 
is greater than 3. 
 
 
 
 
 
 
AGE DISTRIBUTION 
Age range (years) No. of patients Percentage (%) 
21 – 30 22 22 
31 – 40 25 25 
41 – 50 37 37 
51 – 60 14 14 
>60 02 02 
Total 100 100 
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SEX NO. OF PATIENTS PERCENTAGE(%) 
MALE 91 91 
FEMALE 9 9 
TOTAL 100 100 
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Days in hospital No. of patients Percentage (%) 
1 -7 33 33 
8 – 14 37 37 
15 – 21 20 20 
22 – 28 8 8 
>28 2 2 
Total  100 100 
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CLINICAL FEATURES 
SYMPTOMS NO.OF 
PATIENTS 
PERCENTAGE 
PAIN ABDOMEN  95 95 
FEVER 31 31 
VOMITING 25 25 
JAUNDICE 14 14 
ABDMONIAL DISTENSION 13 13 
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SYMPTOMS
ABDOMINAL PAIN
FEVER
VOMITING
JAUNDICE
ABDOMINAL DISTENSION
  
ETOLOGY NO. OF 
PATIENTS 
PERCENTAGE 
(%) 
ALCOHOL 59 59 
GALL STONE DISEASE 23 23 
DRUG INDUCED 02 02 
HYPERTRIGLYCERIDEMIA 03 03 
TRAUMA 02 02 
IDIOPATHIC 11 11 
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OUTCOME 
 
 
 BISAP RANSON 
 ≤2 ≥3 ≤3 >3 
NUMBER OF 
PATIENTS 
86 14 80 20 
ORGAN 
FAILURE 
04 10 O2 12 
PANCREATIC 
NECROSIS 
01 08 02 07 
MORTALITY 00 04 01 03 
 
 
 
 
CORRELATION OF BISAP AND RANSON WITH SEVERITY 
 
 BISAP  ≤2 RANSON ≤ 
3 
X2 P VALUE 
ORGAN 
FAILURE 
4 2 O.2275 0.6334 
PANCREATIC 
NECROSIS 
1 2 O.1204 0.7286 
MORTALITY 0 1 0.9629 0.3265 
 
 
 
BISAP ≥ 3 RANSON >3 X2 P VALUE 
ORGAN 
FAILURE  
10 12 5.5336 0.0187 
PANCREATIC 
NECROSIS 
08 07 5.9744 0.0145 
MORTALITY 04 03 3.9822 0.0460 
 
 
 MAP VS SAP 
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 ANALYSIS OF BISAP SCORE IN PREDICTING ORGAN FAILURE 
  ORGAN FAILURE TOTAL 
YES NO 
BISAP 
SCORE 
 ≥ 3 10 04 14 
 ≤ 2 04 82 86 
TOTAL  14 86 100 
 
PARAMETER ESTIMATE LOWER – UPPER 
95% 
CIs 
SENSITIVY 71.43% 45.35, 88.28 
SPECIFICITY 95.35% 88.64, 98.18 
POSITIVE     PREDICTIVE 
VALUE 
71.43% 45.35, 88.28 
NEGATIVE   PREDICTIVE 
VALUE 
95.35% 88.64, 98.18 
DIAGNOSTIC ACCUARCY 92.00% 85.00, 95.89 
 
 ANALYSIS OF RANSONSCORE IN PREDICTING ORGAN 
FAILURE 
 ORGAN FAILURE TOTAL 
YES NO 
RANSON 
SCORE 
> 3 12 08 20 
≤ 3 02 78 80 
TOTAL 14 86 100 
 
PARAMETER ESTIMATE LOWER – UPPER 
95% CIs 
SENSITIVITY 78.57% 52.41, 92.43 
SPECIFICITY 74.42% 64.29, 82.46 
POSITIVE PREDICTIVE 
VALUE 
43.33% 29.75, 50.39 
NEGATIVE PREDICITIVE 
VALUE 
95.52% 87.64, 98.47 
DIAGNOSTIC ACCUARCY 88% 65.7O, 82.45 
STATISTICAL ANALYSIS OF BISAP SCORE IN PREDICTING 
NECROSIS 
 NECROSIS TOTAL 
YES NO 
BISAP 
SCORE 
≥ 3 08 O6 14 
≤ 2 01 85 86 
TOTAL 09 91 100 
 
PARAMETER ESTIMATE LOWER – UPPER 
95% CIs 
SENSITIVITY 81.82% 52.30, 94.86 
SPECIFICITY 94.38% 87.51,97.58 
POSITIVE PREDICTIVE 
VALUE 
64.29% 38.76, 83.66 
NEGATIVE PREDICITIVE 
VALUE 
97.67% 91.91,99.36 
DIAGNOSTIC ACCUARCY 93.00% 86.25, 96.57 
STATISTICAL ANALYSIS OF RANSON  SCORE IN PREDICTING 
NECROSIS 
 NECROSIS TOTAL 
YES NO 
RANSON 
SCORE 
≥ 3 07 13 20 
≤ 2 02 78 80 
TOTAL 09 91 100 
 
PARAMETER ESTIMATE LOWER – UPPER 
95% CIs 
SENSITIVITY 90.91% 62.26, 98.38 
SPECIFICITY 77.53% 67.82, 84.96 
POSITIVE PREDICTIVE 
VALUE 
43.56% 29.23, 61.22 
NEGATIVE PREDICITIVE 
VALUE 
98.57% 92.34,99.75 
DIAGNOSTIC ACCUARCY 91.00% 85.7O, 95.45 
 
STATISTICAL ANALYSIS OF BISAP SCORE IN PREDICTING 
MORTALITY 
 MORTALITY TOTAL 
YES NO 
BISAP 
SCORE 
> 3 04 10 14 
≤ 3 00 86 86 
TOTAL 04 96 100 
 
PARAMETER ESTIMATE LOWER – UPPER 
95% CIs 
SENSITIVITY 100.00% 51.01,100.00 
SPECIFICITY 95.83% 89.77, 98.37 
POSITIVE PREDICTIVE 
VALUE 
50.00% 21.52, 78.48 
NEGATIVE PREDICITIVE 
VALUE 
100.00% 95.99,100.00 
DIAGNOSTIC ACCUARCY 96% 90.16,98.43 
STATISTICAL ANALYSIS OF RANSON SCORE IN PREDICTING 
MORTALITY 
 MORTALITY TOTAL 
YES NO 
RANSON 
SCORE 
≥ 3 03 17 20 
≤ 2 01 79 80 
TOTAL 04 96 100 
 
PARAMETER ESTIMATE LOWER – UPPER 
95% CIs 
SENSITIVITY 88.57% 62.41, 96.43 
SPECIFICITY 64.42% 54.29, 72.46 
POSITIVE PREDICTIVE 
VALUE 
31.33% 22.75, 70.39 
NEGATIVE PREDICITIVE 
VALUE 
96.52% 87.64, 98.48 
DIAGNOSTIC ACCUARCY 93.01% 85.7O, 95.45 
 
COMPLICATIONS 
 
COMPLICATION NO. 0F PATIENTS PERCENTAGE(%) 
ACUTE RENAL FAILURE 5 35.7 
RESPIRATORY FAILURE 2 14.28 
PANCREATIC NECROSIS 9  
INTRA ABDOMINAL ABCESS 1 7.14 
UGI BLEEDING 1 7.14 
MODS 3 21.4 
SEPTICEMIA 3 21.4 
ENCEPHALOPATHY 1 1.74 
PORTAL VEIN THROMBOSIS 1 1.74 
DIC 1 1.74 
PANCREATIC FISTULA 1 1.74 
PSEUDOCYST 1 1.74 
HYPOCALCEMIA 1 1.74 
  
COMPLICATIONS 
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MANAGEMENT 
Among 100 patients four patients expired, 
In the remaining 96 patient, all except four patients managed conservatively 
Two patient had traumatic injury to the pancreas which was initially managed 
conservatively, later they developed severe pancreatits with intra-abdominal 
abscess, that required laparotomy and drainage procedure. 
One patient with severe disease have developed pseudocyst, underwent and 
internal drainage. 
Another patient who had severe pancreatits underwent necrosectomy initially 
and has developed pancreatic fistula later, which was managed by pancreatic 
duct stenting.  
 
 
 
 
 
 
 
 
DISCUSSION 
 
Acute pancreatitis is a common disorder with wide spectrum of illness. 
Severe acute pancreatitis having high morbidity and mortality rate, multiple 
interventions have been tried to prevent this. Early hospitalization may be 
beneficial to identify those who require aggressive interventions to prevent 
the severe attack of pancreatitis. 
In this study, the two different scoring systems (BISAP and RANSON’S) 
were compared and analyzed to assess the severity in patients with acute 
pancreatitis. An attempt also made to compare this study with previous 
similar studies done by others. 
Acute pancreatitis found to be 10 times more common in males than females 
in this study. This result didn’t match with previous study results ,Vikesh K 
Singh et al (6:1), Papachristou et al (5.1:1). This could be explained by the 
fact that, in this study alcohol has found to be most common etiological factor 
and it’s more common in males. 
In this study, the mean age was 41.18years which matches with the study of 
Sarath et al (40.8 yrs) , nearly matches with Vikesh K. Singh et al(49.6 yrs),  
Papachristou et al l(51.7yrs). 
The mean age of non- survivors in this study was found to be 60 years  as 
compared to survivors being 41.23 years. Taking 60 yrs of age as cut –off 
value, increasing age was found to be correlated well with increasing 
incidence of mortality. Thus age is considered as the significant contributory 
factor in predicting the outcome of severe acute pancreatitis. 
The most common etiological factor in this study was alcohol (59%), which 
was more than Bidarkundi et al (46.67)%, and not correlating with results of  , 
Vikesh K Singh et al (21.4 %), Papachristou et al (14%) wherein gall stone 
disease found to be most common cause, 27 and 36%respectively. 
The mean length of hospital stay was 12.03 ± 6.8 days in this study. In this 
study, increasing BISAP and RANSON’S scores was correlated well with the 
duration of hospital stay. 
The most common presentation was predominantly abdominal pain (95%), 
followed by fever (31%), vomiting(25%) and other manifestations. 
In this study , 86 patients were diagnosed to have mild and moderately severe 
acute pancreatitis grouped under MAP, and 14 patients found to have severe 
acute pancreatitis. All the 14 patients were correctly predicted by BISAP 
score. The scores was assessed by correlating the scores with three factors: 
organ failure, necrosis and mortality. 
The analysis for organ faiure showed BISAP score has sensitivity of 71.43%, 
specificity of 95.35%, PPV of 71.43%, NPV of 95.35%, diagnostic accuracy 
of 92%; whereas RANSON’S score has sensitivity of 78.57%, specificity of 
74.42%, PPV of 43.33%, NPV of 95.52 %, diagnostic accuracy of 88%. This 
correlates well with the study by Papachristou et al where sensitivity of 
(70.42%,80.41%), specificity of (92.4%,71.9%), PPV of (57.7%,40%), NPV 
of (84.3%,90.1%), for BISAP and RANSON’S respectively. Thus by using 
Chi2   test, BISAP ≥ 3 has significant correlation with prediction of the 
occurrence of organ failure (p<0.01), which mathes well with study by Vikesh 
k. Singh et al and B U Wu et al. 
In this study, 7/20 patients with BISAP> 3 and 8/14 patients with RANSON’S 
>3, developed pancreatic necrosis. The statistical analysis for the prediction of 
necrosis has  sensitivity of (81.82%,90.91%), specificity of (94.35%,77.53%), 
PPV of (64.29%,43.56%), NPV of (97.67%,98.57%), diagnostic accuracy of 
(93%,91%) for  BISAP and RANSON’S respectively.  This correlates well 
with the study by Papachristou et al where sensitivity of (80.01%,87.65%), 
specificity of (95%,79.51%), PPV of (56.2%,38.9%), NPV of (84.9%,90.1%), 
for BISAP and RANSON’S respectively. Thus by using Chi2   test, BISAP ≥ 
3 has significant correlation with prediction of the occurrence of organ failure 
(p<0.01), which matches well with study by Vikesh k. Singh et al and B U 
Wu et al. 
In this study, 4 patients with severs acute pancreatitis were expired. All 4 
deaths were correctly predicted by BISAP score. The statistical analysis for 
the prediction of necrosis has  sensitivity of (100%,88.57%), specificity of 
(95.83%64.42%), PPV of (50%,31.33%), NPV of (100%,96.52%), diagnostic 
accuracy of (96%,93%) for  BISAP and RANSON’S respectively.  This 
correlates well with the study by Papachristou et al where sensitivity of 
(100%,100%), specificity of (95.8%,53.1%), PPV of (50%,28.1%), NPV of 
(100%,100%), for BISAP and RANSON’S respectively.  
In this study, patients  developed pancreatic necrosis, acute renal failure, 
MODS , septicemia, 
These complications were more likely seen in patients with BISAP ≥ 3, and 
RANSON’S > 3, hence concluded that these are the patients in high risk 
group, who requires intensive monitoring and probably early intervention if 
necessary. 
 
 
 
 
 
 
 
 
 
 
CONCLUSION AND SUMMARY 
 
 
From this study, alcohol (59%) ,was found to be the most common etiological 
factor for acute pancreatitis. 
Males were more commonly affected than females with a ratio of 10:1. 
The most common age group of patients affected were in 4th decade of life. 
The overall mortality in patients with severe acute pancreatitis was 4% 
BISAP score is equally effective in finding out the frequency of severity and 
predicting mortality in patients with acute pancreatitis as Ranson's score. 
Moreover, its components are easily available and it does not require 48 hours 
for completion of assessment as compared to Ranson's score. It is an accurate 
tool to classify patients into mild and severe disease; it is easy to perform and 
can be done on the bedside of patients with acute pancreatitis in every setup. 
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 Nehahsp jfty; jhs; 
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Nehahspf;fhd jfty;fs;: 
Muha;r;rpd; Nehf;fKk; Mjhuq;fSk;: 
 
jPtpu fiza mow;rp Neha; ekJ ehl;by; kpfTk; gutyhf fhzg;gLk; xU 
Neha; MFk;. xl;L nkhj;jkhf Xh; Mz;bw;F 10-20% Ngh; jPtpu fiza mow;rp 
Nehapdhy; ,wf;f NehpLfpwJ. mth;fSs; 10-30% Ngh; kpfTk; Neha; 
jd;ikahy; ghjpf;fg;gl;lth;fs;. 
 ,e;j Ma;tpy; jPtpu fiza mow;rp Nehapd; fLikia tpiuthf fz;lwpa 
igrhg; (RANSON) vd;w kjPg;gPL KiwAk; uhd;rd; (RANSON) vd;w 
kjPg;gPL KiwAk; xg;gplg;gLfpwJ. ,e;j Ma;tpy; gq;Nfw;f jq;fis 
miof;fpNwhk;. 
 ,e;j Ma;tpy; ,t;tpU kjpg;gPL Kiwfspy; ve;j kjpg;gPL Nehapd; 
jPtpuj;ij kpfTk; Jy;ypakhf fz;lwpa cjTfpwJ vd;gJ Muhag;gLfpwJ. 
 ,t;thW Nehapd; fLikia tpiuahf fz;lwptjd; %yk; Nehahspd; 
mth;fspd; Nehapd; jd;ikf;Nfw;g tifg;gLj;jg;gl;L. mjw;F Vw;whh;Nghy; 
rpfpr;ir mspg;gjw;fhd Kiwfis Muk;g epiyapNyNa fz;lwpa KbAk;. 
 
Ma;T Kiw:  
,e;j Ma;tpy; ePq;fs; kUj;Jtkidapy; mDkjpf;fg;gl;l gpd; cq;fSf;F 
,uj;jg;ghpNrhjidfs;, tapW kw;Wk; EiuaPuy; ];Nfd; Nghd;wit vLf;fg;gLk;. 
 Nkw;$wpa Ma;T Kiwapy; nra;ag;gLk; ghpNrhjidfspdhy; jq;fSf;F 
ve;jtpj gf;ftpisTfNsh. capUf;F VNjDk; Mgj;Njh Vw;gltha;g;gpy;iy vd;gij 
njspTgLj;jpf; nfhs;fpNwd;. NkYk; ,e;j Ma;tpy; xg;gplg;gLk; kjpg;gPLfisf; 
nfhz;L jq;fs; Nehapd; fLikj;jd;ikia mwpa ,aDNk jtpu ,jidf; nfhz;L jq;fs; 
Nehapd; Gjpa rpfpr;ir Kiwfs; vJTk; jug;glkhl;lhJ vd;gJ 
njspTg;gLj;jg;gLfpwJ. 
 
Ma;tpy; cq;fs; chpikfs;: 
  
,e;j Ma;tpy; cq;fs; kUj;Jtg; gjpNtLfs; midj;Jk; kpfTk; me;juq;fkhf 
itj;Jf; nfhs;sg;gLk;. ,e;j Ma;tpd; KbTfs; mwptpay; gj;jphpf;iffspy; 
gpuRhpf;fg;glyhk;. Mdhy;, ngaiu ntspapLtJ %yk; cq;fspd; milahsk; 
ntspf;fg;glkhl;lJ. ,e;j Ma;tpy; cq;fspd; gq;Nfw;G jd;dpr;irahdJ. ve;jtpj 
fhuzq;fs; kw;Wk; Kd;dwptpg;gpd;wp ePq;fs; ,e;j Ma;tpypUe;J ve;j xU 
Neuj;jYk; tpyfpf; nfhs;syhk;. 
 
jhq;fs; ,e;j Ma;tpy; gq;Nfw;gjw;F gpd;tUk; xg;Gjy; gbtj;jpy; ifnaOj;J 
,LkhW Nfl;Lf; nfhs;sg;gLfpwJ. 
 
ehs;:       Nehahsp / cwtpdhpd; 
ifnahg;gk;  
,lJ ngUtpuy; Nuif  
(kUj;Jtuhy; 
gbj;Jfhl;lg;gl;lJ) 
  
 
 
 
PROFORMA 
A COMPARATIVE STUDY BETWEEN BISAP AND APACHE IN 
SCORE IN ASSESSING THE SEVERITY OF ACUTE 
PANCREATITIS 
Patient details: 
Name :      Patient ID No: 
Age : 
Sex : 
Hospital No: 
Date of Admission : 
Date of Surgery (if any) : 
Date of Discharge : 
Address : 
 
 
History :      
Abdominal Pain : 
 Duration 
 Onset 
 Progression 
 Nature of pain 
 Radiation 
 Aggravation / Relieving factors 
Vomiting : 
 Duration 
 Episodes 
 Nature of Vomitus 
 Hematermesis: 
Fever 
Duration 
Grade 
Associated with chils / rigor  
Trauma 
Prodonged Drug intake 
Jaundice 
Malena 
Loss of appetite / Loss weight 
Breathlessness 
Past H/O. 
Previous surgical illness 
DM/HT/TB/COPD/IHD/EPILEPSY/BA 
Presonal H/O: 
Occupation: 
Socio – economic status: 
Smoking: 
Aicoholism: 
Drug addiction: 
Tobacco / Betel nut chewing: 
Family H/O: 
Genreal Examination: 
Ges :    E  V  M 
Vitals:  PR 
            BP 
            RR 
 Temperature: 
BMI : 
Systemic Examination: 
Abdominal Examination: 
 
Cardiovascular system Examination: 
Respiratory system Examination: 
Diagnosis: 
Investigation: 
Complete Hemogram 
Hb:              TC:           DC: 
ESR:           PCV:  Platelet: 
Blood Sugar: 
Blood Urea:  Sr. Creatimine: 
Sr. Electrolytes: Na+  K+  C/-  HCO3- 
Sr. LDH 
Sr. Calcium 
Liver Function Test: 
ABG analysis:  pH  PaCO2 
    PaO2 
 
 
 
Sr. amylase / Sr. lipase: 
Chest X-ray 
Abdomen X-ray 
ECG 
USG abdomen & chest: 
CT scan abdomen: 
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